findmyKOL

Pavan Bhargava, MD

Enriched profile

Associate Professor of Neurology · Johns Hopkins University School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Baltimore, MD · Northeast · United StatesSpecialtyNeurologyFocusMultiple Sclerosis Research Studies+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2023–2025NIH funding2022–2026

Pavan Bhargava is Associate Professor of Neurology at Johns Hopkins University School of Medicine. OpenAlex indexes 182 publications with 4,532 citations (h-index 36); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Pavan Bhargava, MD, is Associate Professor of Neurology at Johns Hopkins University School of Medicine, Department of Neurology. The public record shows 182 publications with 4,532 citations (h-index 36), centered on Multiple Sclerosis Research Studies, Tryptophan and brain disorders, Amyotrophic Lateral Sclerosis Research. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 7 companies, 3 NIH-funded awards (2022–2026).

  • Most recent indexed publication: 2026 · medRxiv
  • Top research focus: Multiple Sclerosis Research Studies
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 7 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Multiple Sclerosis4 trialsALS

Research focus

OpenAlex concept fingerprint
Multiple Sclerosis Research StudiesTryptophan and brain disordersAmyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesNeuroinflammation and Neurodegeneration Mechanisms

Drugs & molecules

across trials, industry payments and publications
Ocrevusgeneric · OcrelizumabClinical trials—Industry payments8Publications1Briumvigeneric · UblituximabClinical trials—Industry payments2Publications—Tysabrigeneric · NatalizumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
EMD Serono, Inc.Clinical trials—Industry payments17Johns Hopkins UniversityClinical trials4Industry payments—F. Hoffmann-La Roche AGClinical trials—Industry payments3Genentech USA, Inc.Clinical trials—Industry payments3Genentech, Inc.Clinical trials—Industry payments2TG Therapeutics, Inc.Clinical trials—Industry payments2Biogen, Inc.Clinical trials—Industry payments1Genzyme CorporationClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
182publications

Distinct works indexed by OpenAlex, matched via ORCID; 33 in PubMed.

4,532citations

Total citations across indexed works.

36h-index

Hirsch index (OpenAlex). i10-index 59.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
7companies · 2023–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
3NIH grants · 2022–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

7 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    77.9%
    Potassium Channel Blocker50.4%
    Dalfampridine Er100%
    Part D<11 patients
    Gabapentinoids19.1%
    Gabapentin100%
    Part D<11 patients

    + 1 more class in this area

  • Musculoskeletal

    13%
    gamma-Aminobutyric Acid-ergic Agonist13%
    Baclofen100%
    Part D<11 patients
  • Cancer & immunology

    9.2%
    Other immunosuppressants9.2%
    Dimethyl Fumarate100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

3 NIH research awards on record, funded 2022–2026 per NIH RePORTER. The latest:

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Peter A. Calabresi79Matthew D. Smith45Fatemeh Siavoshi36Ellen M. Mowry35Kathryn C. Fitzgerald34Philipp Frank27Krishna A. Pucha27Amelia Farinas27Daniel Western27David Zweibaum27Heather E. Dark27Makio Furuichi27Masaki Shibayama27Yukiko Nishita27Cassandra Blew27Cassandra M Joynes27Qu Tian27Muhammad Ali26Iwao Waga26Guray Erus26JINGSHA CHEN26S. Kato26Ming Liu26Sridhar Kandala26Erik C. B. Johnson26Elizabeth Mormino26Masahisa Katsuno26Susan M. Resnick26Kathleen L. Poston26Yuhan Cui26Tony Wyss-Coray26Keenan A. Walker26Allan I. Levey26Rebecca F. Gottesman26Michael R. Duggan26Bennett A. Landman26Christos Davatzikos26Carlos Cruchaga26Abhay Moghekar26David A. Bennett26

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/pavan-bhargava-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/pavan-bhargava-80395590

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • X / Twitter

    x.com/PavanBhargavaMD

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    msdiscovery.org/news/podcasts/30693-episode-86-dr-pavan-bhargava-targeting-lesions-lining-brain

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →msdiscovery.org ↗
  • Other

    consultant360.com/podcast/consultant360/neurology/pavan-bhargava-md-what-multiple-sclerosis

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →consultant360.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    Neurology

    2013
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
  • MBBS

    Christian Medical College, Vellore, India

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗

Editorial & leadership roles

journal and society appointments
  • Program Committee Member

    ACTRIMS Forum 2026

    2026
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →forum.actrims.org ↗
  • Fellow

    American Academy of Neurology (FAAN)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →consultant360.com ↗

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.